N-Q 1 nqdfform.htm QUARTERLY SCHEDULE nqdfform.htm - Generated by SEC Publisher for SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT
INVESTMENT COMPANY

Investment Company Act file number                   811-0523

The Dreyfus Fund Incorporated
(Exact name of Registrant as specified in charter)

c/o The Dreyfus Corporation
200 Park Avenue
New York, New York 10166
(Address of principal executive offices) (Zip code)

Michael A. Rosenberg, Esq.
200 Park Avenue
New York, New York 10166
(Name and address of agent for service)

Registrant's telephone number, including area code:    (212) 922-6000 
Date of fiscal year end:    12/31     
Date of reporting period:    9/30/2009     



FORM N-Q

Item 1. Schedule of Investments.



STATEMENT OF INVESTMENTS         
The Dreyfus Fund Incorporated         
September 30, 2009 (Unaudited)         
 
 
Common Stocks--98.8%    Shares    Value ($) 

 
 
Consumer Discretionary--11.9%         
Autoliv    284,570    9,561,552 
Carnival    306,620    10,204,314 
Home Depot    461,098    12,283,651 
Kohl's    187,610 a    10,703,150 
Newell Rubbermaid    448,320    7,034,141 
News, Cl. A    1,317,076    15,791,741 
Nordstrom    178,400    5,448,336 
Omnicom Group    216,300    7,990,122 
SK Equity Fund, LP (Units)    1.28 c    28,863 
Staples    350,150    8,130,483 
Target    146,220    6,825,550 
Time Warner    347,182    9,991,898 
Viacom, Cl. B    273,160 a    7,659,406 
        111,653,207 
Consumer Staples--8.1%         
Cadbury, ADR    87,976    4,505,251 
Coca-Cola Enterprises    474,170    10,151,980 
CVS Caremark    190,324    6,802,180 
Estee Lauder, Cl. A    198,170    7,348,144 
PepsiCo    348,100    20,419,546 
Philip Morris International    400,565    19,523,538 
Whole Foods Market    234,220 a    7,141,368 
        75,892,007 
Energy--10.4%         
Anadarko Petroleum    111,470    6,992,513 
Chevron    296,470    20,880,382 
ENI, ADR    204,260    10,182,361 
ENSCO International    180,200    7,665,708 
Halliburton    252,912    6,858,973 
Hess    88,920    4,753,663 
Newfield Exploration    204,420 a    8,700,115 
Occidental Petroleum    268,680    21,064,512 
XTO Energy    242,865    10,035,182 
        97,133,409 
Exchange Traded Funds--.5%         
Standard & Poor's Depository         
Receipts (Tr. Ser. 1)    44,460    4,694,531 
Financial--15.8%         
Bank of America    1,488,910    25,192,357 



BlackRock    32,855    7,123,621 
Citigroup    2,012,110    9,738,612 
Franklin Resources    82,600    8,309,560 
Genworth Financial, Cl. A     607,070    7,254,486 
Goldman Sachs Group    88,710    16,353,688 
JPMorgan Chase & Co.     558,080    24,455,066 
Lincoln National     313,670    8,127,190 
MetLife     259,990    9,897,819 
Morgan Stanley     413,310    12,763,013 
State Street     182,530    9,601,078 
Wells Fargo & Co.     308,210    8,685,358 
        147,501,848 
Health Care--15.0%         
Abbott Laboratories     168,510    8,336,190 
Alexion Pharmaceuticals     150,120 a    6,686,345 
AmerisourceBergen     219,340    4,908,829 
Amgen     254,670 a    15,338,774 
Boston Scientific     433,640 a    4,592,248 
CIGNA     336,120    9,441,611 
Covidien     162,365    7,023,910 
Galen Partners II, LP (Units)             0.47 c    60,204 
Gilead Sciences     170,340 a    7,934,437 
Hospira     113,880 a    5,079,048 
King Pharmaceuticals     414,520 a    4,464,380 
Merck & Co.     150,720    4,767,274 
Pfizer    1,475,960    24,427,138 
Roche Holding, ADR     115,410    4,685,646 
Schering-Plough     376,710    10,642,057 
Teva Pharmaceutical Industries,         
ADR     102,570    5,185,939 
Universal Health Services, Cl. B     114,800    7,109,564 
Vertex Pharmaceuticals     240,440 a    9,112,676 
        139,796,270 
Industrial--10.7%         
Cummins     146,550    6,566,905 
Dover     260,630    10,102,019 
FedEx     156,480    11,770,426 
General Electric     473,390    7,773,064 
JetBlue Airways     472,220 a    2,823,876 
KBR     275,535    6,417,210 
Norfolk Southern     343,150    14,793,196 
Parker Hannifin     173,700    9,004,608 
Raytheon     212,260    10,182,112 
Textron     405,560    7,697,529 
Tyco International     359,185    12,384,699 
        99,515,644 



Information Technology--18.6%         
Apple         139,506 a    25,860,227 
Broadcom, Cl. A         303,120 a    9,302,753 
Cisco Systems         920,933 a    21,678,763 
EMC         696,150 a    11,862,396 
Google, Cl. A           40,853 a    20,256,960 
Hewlett-Packard          411,270    19,416,057 
International Business Machines           72,990    8,730,334 
Microsoft      1,006,730    26,064,240 
Oracle         650,648    13,559,504 
Teradata         213,700 a    5,881,024 
Tyco Electronics         281,370    6,268,924 
VMware, Cl. A         116,680 a    4,687,035 
        173,568,217 
Materials--2.9%         
Dow Chemical         430,380    11,220,007 
E.I. du Pont de Nemours & Co.         327,440    10,523,922 
Owens-Illinois         142,840 a    5,270,796 
        27,014,725 
Telecommunication Services--1.6%         
AT & T         563,700    15,225,537 
Utilities--3.3%         
American Electric Power         186,830    5,789,862 
Dominion Resources         226,420    7,811,490 
Mirant         308,430 a    5,067,505 
Sempra Energy         239,230    11,916,046 
        30,584,903 
Total Common Stocks         
(cost $799,955,400)        922,580,298 
 
Other Investment--1.8%         

 
 
Registered Investment Company;         
Dreyfus Institutional Preferred         
Plus Money Market Fund         
       (cost $17,154,000)    17,154,000 b    17,154,000 
 
Total Investments (cost $817,109,400)         100.6%    939,734,298 
Liabilities, Less Cash and Receivables    (.6%)    (6,040,551) 
Net Assets         100.0%    933,693,747 

ADR - American Depository Receipts

a      Non-income producing security.
 
b      Investment in affiliated money market mutual fund.
 
c      Securities restricted as to public resale. Investment in restricted securities with aggregated market value assets of $89,067 representing 0.01% of net assets (see below).
 


    Acquisition    Purchase    Net     
Issuer    Date    Price ($)†    Assets (%)    Valuation ($)†† 

 
 
 
 
Galen Partners II, LP (Units)    5/1/96-1/3/97    946,446    .01    127,987 per unit 
SK Equity Fund, LP (Units)    3/8/95-9/18/96    298,059    .00    22,497 per unit 
† Average cost per unit.                 
†† The valuation of these securities has been determined in good faith under the direction of the Board of Directors.     

At September 30, 2009 , the aggregate cost of investment securities for income tax purposes was $817,109,340. Net unrealized appreciation on investments was $122,624,898 of which $150,007,333 related to appreciated investment securities and $27,382,435 related to depreciated investment securities.



Various inputs are used in determining the value of the fund's investments relating to Fair Value Measurements. 
These inputs are summarized in the three broad levels listed below. 
                                                                         Level 1 - quoted prices in active markets for identical investments. 
                                                                         Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, 
                                                                         credit risk, etc.) 
                                                                         Level 3 - significant unobservable inputs (including fund's own assumptions in determining the fair value of investments). 
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing 
in those securities. 
The following is a summary of the inputs used as of September 30, 2009 in valuing the fund's investments: 

    Level 1 -    Level 2 - Other Significant    Level 3 -Significant     
Assets ($)    Quoted Prices    Observable Inputs    Unobservable Inputs    Total 

 
 
 
 
Investments in Securities:                 

 
 
 
 
Equity Securities - Domestic+    883,675,951    -    -    883,675,951 

 
 
 
 
Equity Securities - Foreign+    34,120,749    -    -    34,120,749 

 
 
 
 
Mutual Funds/Exchange Traded Funds    21,848,531            21,848,531 

 
 
 
 
 
Private Equities    -    -    89,067    89,067 

 
 
 
 
Other Financial Instruments++    -    -    -    - 

 
 
 
 
Liabilities ($)                 

 
 
 
 
Other Financial Instruments++    -    -    -    - 

 
 
 
 

+ See Statement of Investments for industry classification.

++ Other financial instruments include derivative instruments, such as futures, forward foreign currency exchange contracts, swap contracts and options contracts. Amounts shown represent unrealized appreciation (depreciation), or in the case of options, market value at period end.

The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value:

    Investments in 
    Private Equities ($) 

 
Balance as of 12/31/2008    138,464 

 
Realized gain (loss)    0 

 
Change in unrealized appreciation    0 
(depreciation)     

 
Net purchases (sales)    (49,397) 

 
Transfers in and/or out of Level 3    0 

 
Balance as of 9/30/2009    89,067 

 



The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) has become the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the Securities and Exchange Commission (“SEC”) under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The Codification has superseded all existing non-SEC accounting and reporting standards. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fund adopted the provisions of ASC 815 Derivatives and Hedging which requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of gains and losses on derivative instruments and disclosures about credit-risk-related contingent features in derivative agreements. The fund held no derivatives during the period ended September 30, 2009. These disclosures did not impact the notes to the financial statements.

Portfolio valuation: Investments in securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices, except for open short positions, where the asked price is used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. When market quotations or official closing prices are not readily available, or are determined not to reflect accurately fair value, such as when the value of a security has



been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board of Directors. Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant ADRs and futures contracts. For other securities that are fair valued by the Board of Directors, certain factors may be considered such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold and public trading in similar securities of the issuer or comparable issuers. Investments denominated in foreign currencies are translated to U.S. dollars at the prevailing rates of exchange. Forward foreign currency exchange contracts (“forward contracts”) are valued at the forward rate. Financial futures are valued at the last sales price.

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the Securities and Exchange Commission on Form N-CSR.



Item 2. Controls and Procedures.

(a) The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-Q is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-Q is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

(b) There were no changes to the Registrant's internal control over financial reporting that occurred during the Registrant's most recently ended fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.

Item 3. Exhibits.

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940.



FORM N-Q

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

The Dreyfus Fund Incorporated

By:    /s/ J. David Officer 
   
    J. David Officer 
    President 
 
Date:    November 19, 2009 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

By:    /s/ J. David Officer 
   
    J. David Officer 
    President 
 
Date:    November 19, 2009 
 
By:    /s/ James Windels 
   
    James Windels 
Treasurer
 
Date:    November 19, 2009 

EXHIBIT INDEX

(a) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (EX-99.CERT)